Stay updated with breaking news from Bennett Bigelow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PITTSBURGH – A federal judge has granted a final opportunity to amend a class action complaint, for plaintiffs who claimed significant harm was sustained on behalf of themselves and/or their loved ones, based on a shortage of a pharmaceutical drug named Fabrazyme that began in 2009 and lasted until 2012.
Allen Institute Adds Leading Health Care Attorney To Board Of Directors Carla DewBerry brings expertise in health care law and background in nonprofit philanthropic boards to the research organization's governing board News provided by Share this article Share this article SEATTLE, April 8, 2021 /PRNewswire/ -- The Allen Institute today announced the appointment of Carla M. DewBerry, J.D., a partner at K&L Gates LLP, an internationally recognized law firm, to its Board of Directors. The board, which is comprised of members from science, law, finance and other business and philanthropic backg...